Nonalcoholic fatty liver disease as a complication of insulin resistance.
about
Pharmacological treatments for non-alcohol related fatty liver disease (NAFLD): a network meta-analysisDiverse roles of the nucleic acid-binding protein KHSRP in cell differentiation and diseaseNonalcoholic Fatty liver disease and risk of diabetes and cardiovascular disease: what is important for primary care physicians?Review of nonalcoholic fatty liver disease in women with polycystic ovary syndromeNonalcoholic fatty liver disease: new treatmentsChanges in hepatic gene expression upon oral administration of taurine-conjugated ursodeoxycholic acid in ob/ob miceBioinformatics-driven identification and examination of candidate genes for non-alcoholic fatty liver disease.Clinical importance of epicardial adipose tissue.Non-high-density lipoprotein cholesterol (non-HDL-C) levels in children with nonalcoholic fatty liver disease (NAFLD)Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease.Lipid-induced insulin resistance: unravelling the mechanism.Hepatic lipid accumulation alters global histone h3 lysine 9 and 4 trimethylation in the peroxisome proliferator-activated receptor alpha network.Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitisExtracts from Salvia-Nelumbinis naturalis alleviate hepatosteatosis via improving hepatic insulin sensitivity.Does vitamin C deficiency promote fatty liver disease development?KSRP is critical in governing hepatic lipid metabolism through controlling Per2 expression.P2X7 receptor as a key player in oxidative stress-driven cell fate in nonalcoholic steatohepatitis.Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis.NADPH Oxidase-Derived Peroxynitrite Drives Inflammation in Mice and Human Nonalcoholic Steatohepatitis via TLR4-Lipid Raft RecruitmentAntioxidant and Anti-Inflammatory Activities of Kenyan Leafy Green Vegetables, Wild Fruits, and Medicinal Plants with Potential Relevance for Kwashiorkor.A Lipidomic Readout of Disease Progression in A Diet-Induced Mouse Model of Nonalcoholic Fatty Liver Disease.RGC-32 Deficiency Protects against Hepatic Steatosis by Reducing Lipogenesis.The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humansLife style modification improves insulin resistance and liver histology in patients with non-alcoholic fatty liver disease.A Computational Model of Hepatic Energy Metabolism: Understanding Zonated Damage and Steatosis in NAFLDContribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice.Artemisia annua Leaf Extract Attenuates Hepatic Steatosis and Inflammation in High-Fat Diet-Fed Mice.Nuclear receptors reverse McGarry's vicious cycle to insulin resistance.Screening for Nonalcoholic Steatohepatitis in Individuals with Type 2 Diabetes: A Cost-Effectiveness Analysis.Rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.Development of nonalcoholic steatohepatitis in insulin-resistant liver-specific S503A carcinoembryonic antigen-related cell adhesion molecule 1 mutant miceDiet and exercise interventions reduce intrahepatic fat content and improve insulin sensitivity in obese older adults.CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH).Hepatic glucose utilisation in hepatic steatosis and obesity.Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective.RNAi-based therapeutic strategies for metabolic disease.Non-alcoholic fatty liver disease and cardiovascular disease: epidemiological, clinical and pathophysiological evidences.Circadian rhythms in liver physiology and liver diseases.Insulin resistance in the liver: deficiency or excess of insulin?Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies.
P2860
Q24186865-7ADE4648-AB29-4143-8045-68AB476FD6D7Q26771889-380BDF53-8A69-45BB-852E-D912F60FEFDAQ26827169-E1CAF2E1-9372-4EB0-82B2-9167E5014AE1Q26828765-F26E80CB-D22D-43D4-AAE1-A778C7761AD0Q27021161-6F382E2F-968C-45FE-BD91-056E6D7F13B0Q28476015-F3B80231-AB01-46B6-A3DD-40672309C76EQ33826084-71D0610E-706B-4A22-A8F3-CB368CCC8B13Q33897351-641E8F65-3808-4A79-960D-467CA86A4E93Q34037347-0D9CE6F0-45C2-450B-A5D9-D7232B003BC3Q34160784-E8DCDB69-B11A-40F5-866A-139B8670DA1CQ34370958-56452FF6-CE76-479C-99D3-F4662E103D12Q34413666-200773BE-CF49-4E42-BA10-A466D8469ACCQ34499029-8A6D54FD-4958-43ED-BEE1-98A2C20721A1Q34571695-4E75B96C-E6F5-4061-B9B8-69D30D378A2BQ34774959-4C93C069-95AE-455F-8288-31433ED80990Q35014217-119EA202-638C-475B-B409-FAF056DF2B39Q35178036-FC6AE11F-7403-4C4C-8D39-9DF22E937AD2Q35226097-7DAB2773-C1E9-4F25-B232-605CA2E267D1Q35790133-16DBC809-1518-41E2-BEEC-B98C1DC94448Q35876335-34E690A9-C0DF-42D0-A59A-7172709D6497Q35933771-1826C818-62A6-4CF9-BF4F-1EEFB5C1E2F6Q35953156-C97A1262-59D0-44DA-ADB9-770C271FCD2DQ36005304-8DF112CE-DC19-43CC-82AD-F6C6AE8DA6B7Q36131251-F42C87DD-AB69-491E-BC88-2040CCEE5336Q36134426-F6D52DB5-ED76-4DB1-BE8B-A8178145E8CDQ36479005-5DE2B639-8243-4967-88E7-122E7CBEFE8FQ36705993-063F5C88-FA44-415F-A933-954F8E7D6125Q36732028-65C0ABC5-C92E-4493-8131-588A699AC845Q37037308-D33E53DA-D0A7-4D35-BD37-D12AA18DE50DQ37375389-0EBC6F83-9604-4B38-9FB8-07A5C74F789BQ37444112-1709C910-507F-4619-BE1A-0A23F8302189Q37475764-5CBE7286-B3CA-4A45-BDF6-911D91FD89A5Q37624585-CC06AC06-4F3C-469D-A279-C4BA0FC0AD97Q37626809-53C1DE31-CF5E-4F36-B138-CFE36A5399F2Q37863136-D724821A-FB64-4E54-9E7A-8FA1C63DAB01Q37866632-EA3AE74C-33A5-47AD-87F6-2AE3B1885370Q38052857-242BE5BF-B439-4E9C-B830-59035C47557CQ38110525-F1B2C222-772C-4F22-AFBB-97CD9F92F2ACQ38285131-72A310FE-F097-469B-9B55-BB021F4548C4Q38397177-A6010D20-80EC-4651-91E6-4C8F48CCB048
P2860
Nonalcoholic fatty liver disease as a complication of insulin resistance.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Nonalcoholic fatty liver disease as a complication of insulin resistance.
@en
type
label
Nonalcoholic fatty liver disease as a complication of insulin resistance.
@en
prefLabel
Nonalcoholic fatty liver disease as a complication of insulin resistance.
@en
P1476
Nonalcoholic fatty liver disease as a complication of insulin resistance.
@en
P2093
Anna Mae Diehl
Manal F Abdelmalek
P304
1125-49, ix
P356
10.1016/J.MCNA.2007.06.001
P577
2007-11-01T00:00:00Z